BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.480,29 PKT -6,17 PKT -0,42 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
05.06.12 Straumann underperform Exane-BNP Paribas SA
05.06.12 Roche outperform Exane-BNP Paribas SA
05.06.12 Novartis hold Vontobel Research
04.06.12 Novartis neutral Exane-BNP Paribas SA
04.06.12 Roche neutral Citigroup Corp.
04.06.12 Swiss Re neutral Exane-BNP Paribas SA
04.06.12 Novartis neutral Citigroup Corp.
04.06.12 Straumann hold Vontobel Research
04.06.12 Novartis hold Vontobel Research
04.06.12 Zurich Insurance buy Vontobel Research
01.06.12 Swiss Re buy UBS AG
01.06.12 Swiss Re hold Société Générale Group S.A. (SG)
01.06.12 Kühne + Nagel International underperform Cheuvreux SA
01.06.12 Lonza hold Vontobel Research
31.05.12 Swiss Re overweight J.P. Morgan Cazenove
31.05.12 ABB (Asea Brown Boveri) neutral Exane-BNP Paribas SA
31.05.12 Swiss Re buy Sarasin Research
31.05.12 Swiss Re add Commerzbank Corp. & Markets
31.05.12 Holcim overweight Morgan Stanley
31.05.12 Holcim equal-weight Morgan Stanley
31.05.12 Swiss Life hold Société Générale Group S.A. (SG)
31.05.12 Swiss Re buy Vontobel Research
31.05.12 Novartis buy Deutsche Bank AG
30.05.12 Roche buy Deutsche Bank AG
30.05.12 Novartis outperform Credit Suisse Group
30.05.12 Holcim outperform Exane-BNP Paribas SA
29.05.12 Novartis neutral J.P. Morgan Cazenove
29.05.12 Novartis buy UBS AG
29.05.12 Novartis buy UBS AG
29.05.12 UBS neutral Sarasin Research
29.05.12 Richemont kaufen Euro am Sonntag
29.05.12 Swisscom hold Vontobel Research
25.05.12 Zurich Insurance buy ING
23.05.12 Sonova buy Vontobel Research
23.05.12 Novartis hold Vontobel Research
22.05.12 Zurich Insurance halten Independent Research GmbH
22.05.12 Sonova neutral Sarasin Research
22.05.12 Sonova buy Vontobel Research
22.05.12 Lindt neutral Sarasin Research
21.05.12 Straumann hold Vontobel Research